Ligand profile
36I
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04919 — 3-oxoacyl-[acyl-carrier-protein] reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
36I- PDB
4bny- UniProt (similar protein)
O54438- Target protein
- KP13_04919
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.2
- −1 ≤ LogP ≤ 5 3.19
- MW ≤ 500 Da 297.4
- LogP ≤ 5 3.19
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 38.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)c2nc3ccsc3c(n2)N4CCOCC4c1ccc(cc1)c2nc3ccsc3c(n2)N4CCOCC4
InChI=1S/C16H15N3OS/c1-2-4-12(5-3-1)15-17-13-6-11-21-14(13)16(18-15)19-7-9-20-10-8-19/h1-6,11H,7-10H2InChI=1S/C16H15N3OS/c1-2-4-12(5-3-1)15-17-13-6-11-21-14(13)16(18-15)19-7-9-20-10-8-19/h1-6,11H,7-10H2
RBDRSWPTRGNKIG-UHFFFAOYSA-NRBDRSWPTRGNKIG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 36I →
- PDB RCSB structure 4bny →
- UniProt UniProt O54438 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “36I”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04919.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).